Anti-Cancer Medicines Availability Study
Study objectives: to provide health authorities with data on the availability of licensed anti-neoplastic medicines
Launched in April 2014 and April 2015 respectively, these two ambitious projects aim to provide clear and reliable data on medicine availability.
International study: open for peer review
The preliminary data from the international arm (countries not covered in the European Study) is now available for peer review. We invite you to review the data for your country and submit any comments or corrections via the online survey. Review the data here.
- to provide health authorities with data on the availability of licensed anti-neoplastic medicines
- to report on the actual availability of anti-neoplastic medicines to patients when they are prescribed and when patients can afford them
- to provide data so that policy makers can decide how to best address and resolve the challenges identified